People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Other, Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Happy Money, Inc. | — | Other | Series C | $123.7M | $674.0M | 2021 |
| Revalesio Corp | — | Pharmaceuticals | Series B | $103.4M | $624.1M | 2016 |
| Trov, Inc. | — | Other Technology | Series C | $76.5M | $13.4M | 2012 |
| DebtMarket, Inc. | — | Other Technology | Seed | $3.9M | $85.1M | 2010 |
Scott Walchek at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Walchek on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Park | 2 | 5 |
| Bruce Whitley | 2 | 2 |
| Jeffrey Smith | 1 | 11 |
| Lee Huntsman | 1 | 5 |
| James Jones | 1 | 4 |
| Brian Kaas | 1 | 4 |
| Joe Saunders | 1 | 3 |
| Michael Pearson | 1 | 3 |
| Patricia Kemp | 1 | 3 |
| Jacqueline LeSage Krause | 1 | 2 |
| Matt Wilson | 1 | 2 |
| Eric Russell | 1 | 2 |
| CHRIS FIBIGER | 1 | 2 |
| Ken Rudin | 1 | 2 |
| TROY ALSTEAD | 1 | 2 |
| JANE TAYLOR | 1 | 2 |
| Anthony Melman | 1 | 2 |
| Jim Scott Lane | 1 | 1 |
| Mohamed Scott El-Erian | 1 | 1 |
| Eden Warner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.